Journals / İstanbul Kuzey Klinikleri / 2019 / Cilt: 6 - Sayı: 3

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?

Pages
315–316
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Skin prickand oral controlled challenge tests can be performed for determining the cross-reactivity of PPIs to prevent adverse reactions.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Proton pump inhibitors (PPIs) are one of the most prescribed drugs worldwide.
📊
Key Findings & Data:Thereafter, lansoprazole was switched to pantoprazole, which was well tolerated.
💡
Conclusion & Impact:Skin prickand oral controlled challenge tests can be performed for determining the cross-reactivity of PPIs to prevent adverse reactions.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Proton pump inhibitors (PPIs) are one of the most prescribed drugs worldwide. Anaphylactic reactions of PPIs are rare; however,several cases have been reported. Here, we report a rare case of anaphylaxis that occurred immediately following lansoprazole intake. Following the successful management in the emergency department, skin prick and oral controlled challenge tests were performed to evaluate cross-reactivity. Thereafter, lansoprazole was switched to pantoprazole, which was well tolerated. Skin prickand oral controlled challenge tests can be performed for determining the cross-reactivity of PPIs to prevent adverse reactions.

🔖

Cite This Article

BİLGE, S., AYDIN, G., ASLAN, H., AYDIN, A. A., DÜZENLİ, T. (2022). Lansoprazole as an uncommon cause of anaphylaxis: What to give next?. İstanbul Kuzey Klinikleri, Cilt: 6 - Sayı: 3, 315–316. https://ajindex.com/articles/551449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Candar M, Gunes H, Boz BV, Kandis H, Kutlucan L, Saritas A. Asystole after the first dose of lansoprazole. Am J Emerg Med 2014;32:1302.e3–4
  2. Demirkan K, Bozkurt B, Karakaya G, Kalyoncu AF. Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature. J Investig Allergol Clin Immunol 2006;16:203–9
  3. Kara M, Tanoglu A, Kutlu A, Sirkeci O, Kekilli M. Esomeprazole: a safe alternative to lansoprazole allergy? Iran J Allergy Asthma Immunol 2014;13:296–7
  4. Turedi O, Sozener ZC, Kendirlinan R, Bavbek S. A Case of Pantoprazole Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors: Finding a Safe Alternative. Curr Drug Saf 2017;12:198–200. [CrossRef ] 5. Karabacak E, Kutlu A, Aydin E, Ozturk S. Hypersensitivity to lansoprazole with tolerance to other proton pump inhibitors: does cross-reactivity between proton pump inhibitors really exist? Allergol Immunopathol (Madr) 2013;41:136–7. [CrossRef ] 6. Choi SW, Han JM, Bae YJ, Lee YS, Cho YS, Moon HB, et al. Lessons from two cases of anaphylaxis to proton pump inhibitors. J Clin Pharm Ther 2012;37:614–6. [CrossRef ] 7. Aksu K, Kurt E. Anaphylaxis to lansoprazole with tolerance to omeprazole. Allergol Immunopathol (Madr) 2012;40:393–4. [CrossRef ] 8. Lobera T, Navarro B, Del Pozo MD, González I, Blasco A, Escudero R, et al. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2009;19:57–60
  5. Kepil Özdemir S, Öner Erkekol F, Ünal D, Büyüköztürk S, Gelincik A, Dursun AB, et al. Management of Hypersensitivity Reactions to Proton Pump Inhibitors: A Retrospective Experience. Int Arch Allergy Immunol 2016;171:54–60. [CrossRef ] 10. Bose S, Guyer A, Long A, Banerji A. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol 2013;111:452–7. [CrossRef ]